An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis

ConclusionsOsteoporosis is a common feature in ISM but not in AdvSM. An increased BMD is frequently present in AdvSM but not in ISM and is associated with more advanced disease and inferior outcome.

Source: Journal of Cancer Research and Clinical Oncology - January 23, 2020 Category: Cancer & Oncology Source Type: research